Combination chemotherapy plus targeted therapy
This page covers all Combination chemotherapy plus targeted therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Phase 3 pipeline (1)
- FOLFOX plus targeted therapy · Shanghai Zhongshan Hospital · Oncology
FOLFOX chemotherapy combined with targeted therapy agents works by inhibiting DNA synthesis and cell division while blocking specific oncogenic signaling pathways.
Patent intelligence
- combination chemotherapy plus targeted therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates